BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28041956)

  • 21. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele.
    Stice E; Spoor S; Bohon C; Small DM
    Science; 2008 Oct; 322(5900):449-52. PubMed ID: 18927395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
    Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
    Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
    Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
    Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.
    Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y
    Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels.
    Cazorla M; Shegda M; Ramesh B; Harrison NL; Kellendonk C
    J Neurosci; 2012 Feb; 32(7):2398-409. PubMed ID: 22396414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
    Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
    Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
    Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
    J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.
    Kellendonk C; Simpson EH; Polan HJ; Malleret G; Vronskaya S; Winiger V; Moore H; Kandel ER
    Neuron; 2006 Feb; 49(4):603-15. PubMed ID: 16476668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 receptor signaling on iMSNs is required for initiation and vigor of learned actions.
    Augustin SM; Loewinger GC; O'Neal TJ; Kravitz AV; Lovinger DM
    Neuropsychopharmacology; 2020 Nov; 45(12):2087-2097. PubMed ID: 32811899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.
    Bello EP; Casas-Cordero R; Galiñanes GL; Casey E; Belluscio MA; Rodríguez V; Noaín D; Murer MG; Rubinstein M
    Mol Psychiatry; 2017 Apr; 22(4):595-604. PubMed ID: 27431292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate intensity treadmill exercise alters food preference via dopaminergic plasticity of ventral tegmental area-nucleus accumbens in obese mice.
    Chen W; Wang HJ; Shang NN; Liu J; Li J; Tang DH; Li Q
    Neurosci Lett; 2017 Feb; 641():56-61. PubMed ID: 28130186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
    Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
    Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway.
    Robinson SE; Sohal VS
    J Neurosci; 2017 Oct; 37(42):10063-10073. PubMed ID: 28912160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity.
    Dunn JP; Kessler RM; Feurer ID; Volkow ND; Patterson BW; Ansari MS; Li R; Marks-Shulman P; Abumrad NN
    Diabetes Care; 2012 May; 35(5):1105-11. PubMed ID: 22432117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.